Skip to main content
. 2019 Nov 6;24(1):830–840. doi: 10.1111/jcmm.14793

Table 1.

Activity of IM1918 in an in vitro kinase assay

Kinase Activity (average, %) Kinase Activity (average, %)
FGFR3 63.91 ± 0.185 ERK2/MAPK1 99.5 ± 0.695
FGFR1 81.64 ± 2.185 ALK 99.71 ± 0.556
p70S6K/RPS6KB1 85.35 ± 0.056 GRK2 100.33 ± 1.444
FYN 85.89 ± 1.698 ROS/ROS1 100.54 ± 2.611
P38a/MAPK14 87.79 ± 7.829 JAK3 100.84 ± 0.61
YES/YES1 88.15 ± 1.999 JNK3/MAPK10 100.89 ± 2.331
ZAP70 89.47 ± 2.099 AKT2 101.83 ± 3.632
AKT1 90.26 ± 1.076 FAK/PTK2 101.86 ± 0.26
JAK1 91.38 ± 0.141 TAK1/MAP3K7 101.95 ± 8.525
IGF1R 92.08 ± 1.335 ASK1/MAP3K5 102.25 ± 0.841
IKKb/IKBKB 92.18 ± 2.026 JNK1/MAPK8 102.42 ± 2.462
PKA 93.6 ± 1.914 ERK1/MAPK3 102.6 ± 3.873
PAK2 95.07 ± 1.978 SRC/c‐Src 102.66 ± 2.875
SYK 95.6 ± 3.765 PYK2/PTK2B 102.69 ± 0.918
ROCK1 95.77 ± 1.82 TYK2 102.83 ± 12.29
JNK2/MAPK9 96.35 ± 2.736 PDK1/PDPK1 105.71 ± 2.438
FGFR2 96.77 ± 1.601 TYK1/LTK 106.77 ± 3.737
TYRO3/SKY 96.94 ± 0.975 PAK1 107.06 ± 5.566
JAK2 96.97 ± 8.383 RAF1 107.28 ± 8.001
BRAF 97.74 ± 1.883 IRAK4 109.78 ± 1.391
P38b/MAPK11 98.61 ± 2.143 ARAF 119.05 ± 1.864
TGFBR1/ALK5 98.88 ± 0.483 TGFBR2 134.3 ± 2.88
GSK3b 99.19 ± 5.12